Publications by authors named "Scott R Plotkin"

127 Publications

mTOR kinase inhibition disrupts neuregulin 1-ERBB3 autocrine signaling and sensitizes NF2-deficient meningioma cellular models to IGF1R inhibition.

J Biol Chem 2020 Dec 9;296:100157. Epub 2020 Dec 9.

Center for Genomic Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA. Electronic address:

View Article and Find Full Text PDF
December 2020

Familial Nervous System Tumor Syndromes.

Continuum (Minneap Minn) 2020 12;26(6):1523-1552

View Article and Find Full Text PDF
December 2020

Effective provider-patient communication of a rare disease diagnosis: A qualitative study of people diagnosed with schwannomatosis.

Patient Educ Couns 2020 Sep 28. Epub 2020 Sep 28.

Center for Healthcare Organization and Implementation Research (CHOIR), Edith Nourse Rogers Memorial Veterans Hospital, 200 Springs Road, Bedford, MA 01730, USA; Department of Health Law, Policy and Management, Boston University School of Public Health, 715 Albany St., Boston, MA 02118, USA. Electronic address:

View Article and Find Full Text PDF
September 2020

Epigenomic, genomic, and transcriptomic landscape of schwannomatosis.

Acta Neuropathol 2021 01 6;141(1):101-116. Epub 2020 Oct 6.

Princess Margaret Cancer Center and MacFeeters-Hamilton Center for Neuro-Oncology Research, University Health Network, Wilkins Family Chair in Brain Tumor Research, 14-701 PMCRT, 101 College St, Toronto, ON, M5G 1L7, Canada.

View Article and Find Full Text PDF
January 2021

Correlation between NF1 genotype and imaging phenotype on whole-body MRI: NF1 radiogenomics.

Neurology 2020 06 28;94(24):e2521-e2531. Epub 2020 Apr 28.

From the Department of Radiology (Y.L., M.A.B., M.V., G.J.H., W.C.), Department of Neurology and Cancer Center (J.T.J., S.R.P.), and Center for Genomic Medicine (S.E., J.A.W.), Massachusetts General Hospital and Harvard Medical School, Boston.

View Article and Find Full Text PDF
June 2020

Benign Intracranial Tumors.

Neurol Clin 2018 08;36(3):501-516

Department of Neurology and Cancer Center, Massachusetts General Hospital, Harvard Medical School, 55 Fruit Street, Yawkey 9E, Boston, MA 02114, USA. Electronic address:

View Article and Find Full Text PDF
August 2018

Considerations for development of therapies for cutaneous neurofibroma.

Neurology 2018 07;91(2 Suppl 1):S21-S30

From the Department of Neurology (S.K.V., J.O.B.), The Johns Hopkins University School of Medicine, The Neurofibromatosis Therapeutic Acceleration Program, Baltimore, MD; The NF Institute (V.M.R.), La Crescenta, CA; Department of Neurology and Cancer Center (S.R.P.), Massachusetts General Hospital, Boston; Division of Plastic Surgery (H.W.), Mount Sinai Hospital, Icahn School of Medicine at Mount Sinai, New York, NY; Department of Dermatology (R.R.A.), Harvard Medical School, Boston, MA; BioPharm Tech (K.J.), San Mateo, CA; and Dermavant Sciences (J.L.), Durham, NC.

View Article and Find Full Text PDF
July 2018

Cutaneous neurofibromas: Current clinical and pathologic issues.

Neurology 2018 07;91(2 Suppl 1):S5-S13

From the Departments of Pathology (N.O.) and Dermatology (P.W.), French Referral Center for Neurofibromatoses, Henri-Mondor Hospital, AP-HP, University Paris Est Créteil, France; Department of Neurology (J.O.B., S.K.V.), Johns Hopkins University School of Medicine, The Neurofibromatosis Therapuetic Acceleration Program, Baltimore, MD; University of Alabama at Birmingham (B.K.); Cancer Center and Department of Neurology (S.R.P.) and Department of Pathology, Division of Neuropathology (A.S.-R.), Massachusetts General Hospital, Boston; The Neurofibromatosis Institute (V.M.R.), La Crescenta, CA; Department of Pathology & Anatomical Sciences (D.C.M.), University of Missouri School of Medicine, Columbia; Manchester Centre for Genomic Medicine (S.H.), Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, UK; Institute of Biomedicine (J.P.), University of Turku, Finland; Department of Pathology and Laboratory Medicine (A.R.), Jackson Memorial Hospital/University of Miami Miller School of Medicine, FL; Department of Pathology and Laboratory Medicine (S.L.C.), Medical University of South Carolina, Charleston; Clinics and Polyclinics of Neurology (V.M.), University Hospital Hamburg-Eppendorf, Hamburg, Germany; and Division of Cancer and Genetics (M.U.), Institute of Medical Genetics, Cardiff University, UK.

View Article and Find Full Text PDF
July 2018

Neurofibromatosis and Schwannomatosis.

Semin Neurol 2018 02 16;38(1):73-85. Epub 2018 Mar 16.

Department of Neurology, University Hospital of Heidelberg, Heidelberg, Germany.

View Article and Find Full Text PDF
February 2018